Skip to content

Clinical trials

Phase 2/3 Lymphoma, Large B-Cell, Diffuse trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Phase: Phase 2/3 Country / region: Spain Clear all

4 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20162
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene1
Incyte Corporation1
Karyopharm Therapeutics Inc1
TG Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse4
Lymphoma, Non-Hodgkin2
Recurrence2
Leukemia, Lymphocytic, Chronic, B-Cell1
Lymphoma, B-Cell, Marginal Zone1
Lymphoma, Follicular1
Lymphoma, Mantle-Cell1

Trials

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.